Cargando…
Probiotics may not prevent the deterioration of necrotizing enterocolitis from stage I to II/III
BACKGROUND: Probiotic therapy can reduce the incidence of NEC. Therapeutic use of probiotics after NEC diagnosis reduces the severity of NEC in preterm infants or full-term infants is unclear. To evaluate the effect of probiotics on preventing the deterioration of necrotizing enterocolitis (NEC) fro...
Autores principales: | Wang, Zheng-Li, Liu, Li, Hu, Xiao-Yu, Guo, Lu, Li, Qiu-Yu, An, Yao, Jiang, Ya-Jun, Chen, Shi, Wang, Xue-Qiu, He, Yu, Li, Lu-Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556034/ https://www.ncbi.nlm.nih.gov/pubmed/31176363 http://dx.doi.org/10.1186/s12887-019-1524-5 |
Ejemplares similares
-
Broad-spectrum Antibiotic Plus Metronidazole May Not Prevent the Deterioration of Necrotizing Enterocolitis From Stage II to III in Full-term and Near-term Infants: A Propensity Score-matched Cohort Study
por: Luo, Li-Juan, et al.
Publicado: (2015) -
Fecal HBD-2 and Claudin-3 may be potential biomarkers to predict the deterioration of necrotizing enterocolitis: A prospective study
por: Liu, Xiao-Chen, et al.
Publicado: (2022) -
Risk factors of necrotizing enterocolitis in neonates with sepsis: A retrospective case-control study
por: Wang, Zheng-Li, et al.
Publicado: (2020) -
Differences in the Clinical Characteristics of Early- and Late-Onset Necrotizing Enterocolitis in Full-Term Infants: A Retrospective Case-Control Study
por: Li, Qiu-Yu, et al.
Publicado: (2017) -
Autoinducer-2 May Be a New Biomarker for Monitoring Neonatal Necrotizing Enterocolitis
por: Fu, Chun-Yan, et al.
Publicado: (2020)